Publication Name	World Journal of Methodology
Manuscript ID	76138
Country	India

Received	2022-03-05 05:43
Peer-Review Started	2022-03-05 05:45
To Make the First Decision
Return for Revision	2022-06-16 08:52
Revised	2022-06-29 09:57
Second Decision	2022-08-29 04:00
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-08-31 05:13
Articles in Press	2022-08-31 05:13
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-08-22 16:51
Typeset the Manuscript	2022-09-13 02:42
Publish the Manuscript Online	2022-09-16 10:39

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biochemistry & Molecular Biology
Manuscript Type	Systematic Reviews
Article Title	Growth differentiation factor 15 as an emerging novel biomarker in SARS-CoV-2 infection
Manuscript Source	Invited Manuscript
All Author List	Deepak Parchwani, Sagar Dholariya, CDS Katoch and Ragini Singh
ORCID	Author(s) ORCID Number Deepak Parchwani http://orcid.org/0000-0001-5024-970X Sagar Dholariya http://orcid.org/0000-0002-0654-5998
Funding Agency and Grant Number
Corresponding Author	Sagar Dholariya, MD, Assistant Professor, Department of Biochemistry, All India Institute of Medical Sciences, Jamnagar Road, Khandheri, Rajkot 360001, Gujarat, India. drsagar.dholariya@gmail.com
Key Words	SARS-CoV-2; Growth differentiation factor 15; Biomarker; Risk-stratification; Prognosis
Core Tip	Growth differentiation factor (GDF)-15 levels are higher in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and higher levels are associated with disease severity, viremia and hypoxemia. The consistent increase in the concentration of GDF-15 during a hospital stay is associated with worse outcomes. Hence, serial monitoring of GDF-15 concentrations may provide useful prognostic value for hospitalized patients with SARS-CoV-2. GDF-15 appears to be involved in the underlying pathophysiology, laying the foundation for a novel therapeutic approach for SARS-CoV-2.
Publish Date	2022-09-16 10:39
Citation	Parchwani D, Dholariya S, Katoch C, Singh R. Growth differentiation factor 15 as an emerging novel biomarker in SARS-CoV-2 infection. World J Methodol 2022; 12(5): 438-447
URL	https://www.wjgnet.com/2222-0682/full/v12/i5/438.htm
DOI	https://dx.doi.org/10.5662/wjm.v12.i5.438

Full Article (PDF)	WJM-12-438.pdf
Full Article (Word)	WJM-12-438.docx
Manuscript File	76138_Auto_Edited-LM.docx
Answering Reviewers	76138-Answering reviewers.pdf
Audio Core Tip	76138-Audio core tip.aac
Biostatistics Review Certificate	76138-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	76138-Conflict-of-interest statement.pdf
Copyright License Agreement	76138-Copyright license agreement.pdf
Peer-review Report	76138-Peer-review(s).pdf
Scientific Misconduct Check	76138-Bing-Liu JH-2.jpg
Scientific Misconduct Check	76138-CrossCheck.jpg
Scientific Editor Work List	76138-Scientific editor work list.pdf